Human herpes virus 6 and multiple sclerosis: a Finnish twin study

Abstract

Objective To investigate the possible association of human herpes virus 6- (HHV6) infection and multiple sclerosis (MS).

Background Despite intensive investigations of genetic and environmental factors, the etiopathogenesis of MS remains unknown. HHV6 is a possible candidate in that it is neurotropic, able to induce demyelination and become latent and be reactivated. We had access to The Finnish National Twin Cohort, which provided a unique opportunity to study the association between HHV6 and MS in genetically homogenous patients.

Methods Thirty-four serum samples from 17 MS twin pairs and 12 cerebrospinal fluid (CSF) samples from six MS twin pairs were tested by PCR specific for HHV6. Immunogloubulin (Ig) G and M response against HHV6 in serum and CSF were analysed using ELISA method. The samples were collected during a remission of the disease.

Results No HHV6 DNA was found in any serum (n = 34) or CSF (n = 12) samples. Eighty-eight percent of the twins with MS and 86% of the healthy twin siblings were positive for IgG in serum. One twin with MS was also postitive for IgM in serum, whereas none of the healthy twins was IgM positive. All CSF samples were negative for IgG and IgM in both groups.

Conclusions During a clinical remission of MS the detection of antibodies against HHV6 in CSF and HHV6 DNA in serum, CSF supernatant or CSF leukocytes is unlikely. However, the results do not exclude a possibility of HHV6 reactivation during MS exacerbation or acute HHV6 infection being one of the triggering agents in development of MS long before its clinical manifestation. Multiple Sclerosis 2008; 14: 54—58. http://msj.sagepub.com

Get full access to this article

View all access options for this article.

References

Ebers GC , Bulman DE , Sadovnick AD , Paty DW , Warren S. , Hader W. et al. A population based study of multiple sclerosis in twins. New Engl J Med 1986; 315: 1638—42.

Mumford CJ , Wood NW , Kellar-Wood HF , Thorpe J. , Miller D. , Compston DA The British Isles survey of multiple sclerosis in twins. Neurology 1994; 44: 11—15.

Andersen O. , Lygner P-E. , Bergstöm T. , Andresson M. , Vahlne A. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 1993; 249: 417—22.

Hunter SF , Hafler DA

Ubiquitous pathogens. Links between infection and autoimmunity in MS?

Neurology 2000; 55: 164—65.

Wolfson C. Multiple sclerosis and antecedent infections. Epidemiology 2001; 12: 301.

Vastag B. Not so fast: Research on infectious links to MS questioned. JAMA 2001; 285: 279—81.

Compston DA , Vakarelis BN , Paul E. , McDonald WI , Batchelor JR , Mims CA Viral infection in patients with multiple sclerosis and HLA-DR matched controls . Brain 1986; 109: 32—44.

Clark D. Human herpes virus type 6 and multiple sclerosis. Herpes 2004; 11(Suppl 2): 112—19.

Höllsberg P. , Kusk M. , Bech E. , Hansen HJ , Jakobsen J. , Haahr S. Presence of Epstein-Barr virus and human herpes virus 6B DNA in multiple sclerosis patients: association with disease activity . Acta Neurol Scand 2005; 112: 395—402.

10.

Knox KK , Brewer JH , Henry JM , Harrington DJ , Carrigan DR Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease. Clin Infect Dis 2000; 31: 894—903.

11.

Soldan SS , Berti R. , Salem N. , Secchiero P. , Flamand L. , Calabresi PA et al. Association of human herpes vierus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997; 3: 1394—97.

12.

Levin LI , Munger KL , Rubertone MV , Peck CA , Lennette ET , Spiegelman D. et al. Multiple sclerosis and Epstein-Barr virus. JAMA 2003; 289: 1533—36.

13.

Sriram S. , Stratton CV , Yao S. , Thrap A. , Ding L. , Banna JD et al. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 1999; 461: 6—14.

14.

Sriram S. Failure to detect chlamydia pneumoniae in the central nervous system of patients with MS. Neurology 2000; 55: 1423—24.

15.

De Alvarez-Lafuente, R. , Las Heras V. , Bartolome M. , Garcia-Montojo M. , Arroyo R. Human herpes virus 6 and multiple sclerosis: a one-year follow-up study. Brain Pathol 2006 ; 16: 20—27.

16.

Alvarez-Lafuente R. , De las Heras V. , Bartolome M. , Picazo J. , Arroyo R. Relapsing-remitting multiple sclerosis and human herpes virus 6 active infection. Arch Neurol 2004; 61: 1523—27.

17.

Yoshikawa T. , Asano, Y. Central nervous system complications in human herpes virus-6 infection. Brain Dev 2000; 22: 307—14.

18.

Berardelli P. Herpes virus linked to multiple sclerosis . Science 1997; 278: 1710.

19.

Moore FG , Wolfson C. Human herpes virus 6 and multiple sclerosis. Acta Neurol Scand 2002; 106: 63—83.

20.

Swanborg RH , Whittum-Hudson JA Human herpes virus 6 and chlamydia pneumoniae as etiologic agents in multiple sclerosis — a critical review. Microbes Infect 2002; 4: 1327—33.

21.

Swanborg FH , Whittum-Hudson JA , Hudson PA

Infectious agents and multiple sclerosis — are chlamydia pneumoniae and human herpes virus 6 involved?

J Neuroimmunol 2003; 136: 1—8.

22.

Fotheringham J. , Jacobson S. Human herpes virus 6 and multiple sclerosis: potential mechanism for virus-induced disease. Herpes 2005; 12: 4—9.

23.

Berti R. , Brennan MB , Soldan SS , Ohayon JM , Casareto L. , McFarland HF et al. Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J Neurovirol 2002; 8: 250—56.

24.

Chapenko S. , Millers A. , Nora Z. , Logina I. , Kukaine R. , Murovska R. Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J Med Virol 2003; 69: 111—17.

25.

Kinnunen E. , Valle M. , Piirainen L. , Kleemola M. , Kantanen ML , Juntunen J. et al. Viral antibodies in multiple sclerosis. A nationwide co-twin study. Arch Neurol 1990; 47: 743—46.

26.

Poser CD , Paty DW , Scheinberg L. , McDonald W. , Davis FA , Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227—31.

27.

Isaacson E. , Glaser C. , Forghani B. , Amad Z. , Wallace M. , Armstrong R. et al. Clin Infect Dis 2005; 40: 890—93.

28.

Meinl E. Concepts of viral pathogenesis of multiple sclerosis. Curr Opin Neurol 1999; 12: 303—307.

29.

Stohlman SA , Hinton DR Viral induced demyelination. Brain Pathol 2001; 11: 92—106.

30.

Tejada-Simon MV , Zang YC , Hong J. , Rivera VM , Zhang JZ Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 2003; 53: 189—97.

31.

Stüve O. , Racke M. , Hemmer B. Viral pathogens in multiple sclerosis. Arch Neurol 2005; 1500—502.

32.

Ongradi J. , Rajda C. , Marodi CL , Csiszar A. , Vecsei L. A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients . J Neurovirol 1999; 5: 529—32.

33.

Ablashi DV , Lapps W. , Kaplan M. , Whitman JE , Richert JR , Pearson GR Human herpes virus-6 (HHV6) infection in multiple sclerosis: a preliminary report. Mult Scler 1998; 4: 490—96.

34.

Nielsen L. , Larsen AM , Munk M. , Vestergaard BF Human herpes virus-6 immunoglobulin G antibodies in patients with multiple sclerosis. Acta Neurol Scand 1997; 169: 76—78.

35.

Prat A. , Antel J. Pathogenesis of multiple sclerosis. Curr Opin Neurol 2005; 18: 225—30.

36.

Enbom M. , Wang F-Z. , Fredriksson S. , Martin C. , Dahl H. , Linde A. Similar humoral and cellular immunological reactivities to human herpes virus 6 in patients with multiple sclerosis and controls. Clin Diagn Lab Immunol 1999; 4: 545—49.

37.

Secchiero P. , Carrigan DR , Asano Y. , Benedetti L. , Crowley RW , Komaroff AL et al. Detection of human Herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Inf Dis 1995; 171: 273—80.

38.

Kuusisto H. , Hyöty H. , Kares S. , Kinnunen E. , Saarelainen M. , Elovaara I. Enteroviruses and the risk of MS in the Finnish Twin Cohort. Eur J Neurol 2005; 12: 707—709.